![Keld Søndergaard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Keld Søndergaard worked as a Director at Xintela AB in 2017 and as the Chief Financial Officer at AFYX Therapeutics AS.
Former positions of Keld Søndergaard
| Companies | Position | End |
|---|---|---|
| XINTELA AB | Director/Board Member | 16/10/2017 |
AFYX Therapeutics AS
 AFYX Therapeutics AS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Director of Finance/CFO | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
2
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Xintela AB
 Xintela AB BiotechnologyHealth Technology Provides treatment and medicine for articular cartilage injuries and diseases | Health Technology |
AFYX Therapeutics AS
AFYX Therapeutics AS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
- Stock Market
- Insiders
- Keld Søndergaard
